Anixa Biosciences Inc [ANIX] stock is trading at $4.44, up 8.03%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ANIX shares have gain 30.97% over the last week, with a monthly amount glided 48.99%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Anixa Biosciences Inc [NASDAQ: ANIX] stock has seen the most recent analyst activity on March 21, 2025, when Maxim Group initiated its Buy rating and assigned the stock a price target of $10. Previously, Chardan Capital Markets started tracking the stock with Buy rating on December 23, 2022, and set its price target to $8. On April 12, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock.
Anixa Biosciences Inc [ANIX] stock has fluctuated between $2.07 and $4.20 over the past year. Currently, Wall Street analysts expect the stock to reach $5.83 within the next 12 months. Anixa Biosciences Inc [NASDAQ: ANIX] shares were valued at $4.44 at the most recent close of the market. An investor can expect a potential return of 31.31% based on the average ANIX price forecast.
Analyzing the ANIX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.5 and Total Capital is -0.77. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.18 points at the first support level, and at 3.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.60, and for the 2nd resistance point, it is at 4.76.
Ratios To Look Out For
For context, Anixa Biosciences Inc’s Current Ratio is 8.45. As well, the Quick Ratio is 8.45, while the Cash Ratio is 0.72.
Transactions by insiders
Recent insider trading involved Titterton Lewis H jr, Director, that happened on Jul 31 ’25 when 10000.0 shares were purchased. Chief Executive Officer, KUMAR AMIT completed a deal on Jul 30 ’25 to buy 5000.0 shares. Meanwhile, Director Baskies Arnold M bought 5000.0 shares on Jul 18 ’25.
